On day 4, a striking treatment-induced effector population C4 emerged within tumor-reactive TILs, most prominently in the CD8-mIL2 + anti–PD-1 group (>66%), while being nearly absent in vehicle-treated animals (<3%). Here, CD8A is linked to neoplasm.